To test the performance of Visinets graphical approach we have; a) built the “de novo” model of EGFR and Erk1/2 signaling with manual parameter adjustment and; b) translated existing model of insulin signaling in diabetes from published ODE model [2] into CMAP formalism. The gene discussed is INS; the disease is diabetes mellitus.